OPKO HEALTH INC (OPK) — insider trading
Health Care · NASDAQ
OPKO HEALTH INC (OPK) has 31 reported SEC Form 4 insider transactions in our data, including 22 open-market purchases among the most recent 31 (latest 2026-07-24).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-24 | Rubin Steven D | Director, Officer (Executive VP-Administration) | Shares withheld for taxes / exercise cost | 53,266 | $1.22 | $65.0K | Form 4 |
| 2026-07-24 | Logal Adam | Officer (Sr. Vice President, CFO) | Shares withheld for taxes / exercise cost | 53,266 | $1.22 | $65.0K | Form 4 |
| 2026-06-18 | Yu Alice Lin-Tsing | Director | Grant / award / vesting (derivative) | 30,000 | — | $0 | Form 4 |
| 2026-06-18 | UPPALURI SUBBARAO V | Director | Grant / award / vesting (derivative) | 80,000 | — | $0 | Form 4 |
| 2026-06-18 | PFENNIGER RICHARD C JR | Director | Grant / award / vesting (derivative) | 60,000 | — | $0 | Form 4 |
| 2026-06-18 | PAGANELLI JOHN A | Director | Grant / award / vesting (derivative) | 30,000 | — | $0 | Form 4 |
| 2026-06-18 | MEDEL ROGER MD | Director | Grant / award / vesting (derivative) | 30,000 | — | $0 | Form 4 |
| 2026-06-18 | Lachman Prem A | Director | Grant / award / vesting (derivative) | 30,000 | — | $0 | Form 4 |
| 2026-03-20 | PAGANELLI JOHN A | Director | Open-market purchase | 10,000 | $1.14 | $11.3K | Form 4 |
| 2026-03-18 | UPPALURI SUBBARAO V | Director | Grant / award / vesting (derivative) | 50,000 | — | $0 | Form 4 |
| 2025-11-21 | FROST PHILLIP MD ET AL; Frost Gamma Investments Trust | Director, Officer (CEO & Chairman), 10% owner | Open-market purchase | 192,870 | $1.34 | $257.5K | Form 4 |
| 2025-11-21 | FROST PHILLIP MD ET AL; Frost Gamma Investments Trust | Director, Officer (CEO & Chairman), 10% owner | Open-market purchase | 191,490 | $1.33 | $254.7K | Form 4 |
| 2025-11-21 | FROST PHILLIP MD ET AL; Frost Gamma Investments Trust | Director, Officer (CEO & Chairman), 10% owner | Open-market purchase | 89,375 | $1.33 | $118.4K | Form 4 |
| 2025-11-21 | FROST PHILLIP MD ET AL; Frost Gamma Investments Trust | Director, Officer (CEO & Chairman), 10% owner | Open-market purchase | 3,894 | $1.32 | $5.1K | Form 4 |
| 2025-11-21 | FROST PHILLIP MD ET AL; Frost Gamma Investments Trust | Director, Officer (CEO & Chairman), 10% owner | Open-market purchase | 102,371 | $1.30 | $133.1K | Form 4 |
| 2025-11-20 | FROST PHILLIP MD ET AL; Frost Gamma Investments Trust | Director, Officer (CEO & Chairman), 10% owner | Open-market purchase | 13,664 | $1.35 | $18.4K | Form 4 |
| 2025-11-20 | FROST PHILLIP MD ET AL; Frost Gamma Investments Trust | Director, Officer (CEO & Chairman), 10% owner | Open-market purchase | 1,757 | $1.35 | $2.4K | Form 4 |
| 2025-11-20 | FROST PHILLIP MD ET AL; Frost Gamma Investments Trust | Director, Officer (CEO & Chairman), 10% owner | Open-market purchase | 24,579 | $1.34 | $32.9K | Form 4 |
| 2025-11-20 | FROST PHILLIP MD ET AL; Frost Gamma Investments Trust | Director, Officer (CEO & Chairman), 10% owner | Open-market purchase | 161,818 | $1.34 | $216.0K | Form 4 |
| 2025-11-20 | FROST PHILLIP MD ET AL; Frost Gamma Investments Trust | Director, Officer (CEO & Chairman), 10% owner | Open-market purchase | 211,948 | $1.33 | $281.9K | Form 4 |
| 2025-11-20 | FROST PHILLIP MD ET AL; Frost Gamma Investments Trust | Director, Officer (CEO & Chairman), 10% owner | Open-market purchase | 47,105 | $1.33 | $62.4K | Form 4 |
| 2025-11-20 | FROST PHILLIP MD ET AL; Frost Gamma Investments Trust | Director, Officer (CEO & Chairman), 10% owner | Open-market purchase | 119,129 | $1.32 | $157.3K | Form 4 |
| 2025-11-19 | FROST PHILLIP MD ET AL; Frost Gamma Investments Trust | Director, Officer (CEO & Chairman), 10% owner | Open-market purchase | 155,496 | $1.32 | $205.3K | Form 4 |
| 2025-11-19 | FROST PHILLIP MD ET AL; Frost Gamma Investments Trust | Director, Officer (CEO & Chairman), 10% owner | Open-market purchase | 198,904 | $1.32 | $261.6K | Form 4 |
| 2025-11-19 | FROST PHILLIP MD ET AL; Frost Gamma Investments Trust | Director, Officer (CEO & Chairman), 10% owner | Open-market purchase | 66,504 | $1.31 | $87.1K | Form 4 |
| 2025-11-19 | FROST PHILLIP MD ET AL; Frost Gamma Investments Trust | Director, Officer (CEO & Chairman), 10% owner | Open-market purchase | 12,993 | $1.31 | $17.0K | Form 4 |
| 2025-11-19 | FROST PHILLIP MD ET AL; Frost Gamma Investments Trust | Director, Officer (CEO & Chairman), 10% owner | Open-market purchase | 30,082 | $1.30 | $39.1K | Form 4 |
| 2025-11-19 | FROST PHILLIP MD ET AL; Frost Gamma Investments Trust | Director, Officer (CEO & Chairman), 10% owner | Open-market purchase | 21,236 | $1.30 | $27.5K | Form 4 |
| 2025-11-19 | FROST PHILLIP MD ET AL; Frost Gamma Investments Trust | Director, Officer (CEO & Chairman), 10% owner | Open-market purchase | 300 | $1.29 | $387 | Form 4 |
| 2025-11-19 | FROST PHILLIP MD ET AL; Frost Gamma Investments Trust | Director, Officer (CEO & Chairman), 10% owner | Open-market purchase | 58,160 | $1.29 | $74.7K | Form 4 |
| 2025-11-19 | FROST PHILLIP MD ET AL; Frost Gamma Investments Trust | Director, Officer (CEO & Chairman), 10% owner | Open-market purchase | 36,325 | $1.28 | $46.5K | Form 4 |
Ask the chat about OPK's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: OPKO HEALTH INC (OPK).
Last updated 2026-07-24 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.